Jill Corre

55PUBLICATIONS
244CO-AUTHORS
Medical mycologyPredictive and prognostic markersMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Aug 13, 2026
Clinical outcomes of newly diagnosed myeloma patients with SLIM criteria : a subgroup analysis of the CASSIOPEIA study.

|Jul 03, 2026
Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial.

|Jul 02, 2026
Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma.

|Jun 04, 2026
PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple Myeloma.

|Apr 16, 2026
Does minimal residual disease matter in t(11;14) myeloma?

|Mar 27, 2026
FDG-PET medullary total tumor volume highlights high-risk patients with newly diagnosed multiple myeloma in CASSIOPEIA trial.

Bastien Jamet, Shamimeh Ahrari, Sonja Zweegman

Pageof 10

Frequent Collaborators

30 joint publications

Aurore Perrot

18 joint publications

Xavier Leleu

14 joint publications

Herve Avet-Loiseau

9 joint publications

Cyrille Touzeau